
Diabetes
Latest News

Latest Videos

CME Content
More News

Prior data had indicated that sodium-glucose cotransporter 2 (SGLT2) inhibitors could be linked to diabetic ketoacidosis, a serious complication of diabetes.

This week, the top managed care stories included findings that some cancers are being diagnosed earlier after people gain coverage under the Affordable Care Act; a new poll gauged Americans' views on Medicaid; and JDRF launched a new campaign to meet the needs of people with type 1 diabetes.

Being isolated due to being overweight can have long-term health consequences, and the study's lead author said reducing stigma should be part of anti-bullying efforts.

While alcohol is known to limit skeletal muscle growth, few studies have looked at the relationship between sarcopenia and problem drinking.

The enzyme that affects the body's ability to process LDL cholesterol was found to be correlated with A1C levels. A symposium on the topic will be part of this weekend's 77th Scientific Sessions of the American Diabetes Association.

When the World Health Organization (WHO) updates its Essential Medicines List every 2 years, observers anticipate the addition of some new drugs or alternate indications. The 20th edition, released Tuesday, also includes a more drastic change by categorizing antibiotics.

The study said the alternative to BMI offers a better way to measure visceral fat, which poses a greater cardiovascular threat.

Amid recent efforts to curtail sodium levels in packaged foods to prevent hypertension and heart disease, the amount of sodium in foods and beverages purchased by US households has decreased, according to a new study. However, most Americans are still buying sodium-dense foods, indicating the need for intensified initiatives to lower sodium intake.

Researchers from the United Kingdom combed studies to figure out which of several indicators, such as body mass index or waist circumference, were predictors of future cardiac events or health conditions, like hypertension or prediabetes.

While regulators long ago saw enough cardiovascular safety data to approve insulin degludec, full trial results will be presented June 12 at the American Diabetes Association Scientific Sessions in San Diego.





























